title: Reduction of migrainous headaches during the use of acenocoumarol.
abstract: Disappearance of migraine during the use of warfarin and of phenprocoumon has been described in sporadic case reports. Treatment with heparin has also been associated with a reduction of migranous headaches. Recently, the Netherlands Pharmacovigilance Foundation LAREB received a case report concerning the diminution of migrainous headaches associated with the use of the vitamin K antagonist, acenocoumarol.
authors.affiliation: Netherlands Pharmacovigilance Centre LAREB.
authors.forename: E P
authors.initials: EP
authors.lastname: van Puijenbroek
authors.forename: A C
authors.initials: AC
authors.lastname: Egberts
authors.forename: J F
authors.initials: JF
authors.lastname: Trooster
authors.forename: J
authors.initials: J
authors.lastname: Zomerdijk
mesh_terms: D000074:Acenocoumarol / Q000627:therapeutic use*; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D013927:Thrombosis / Q000188:drug therapy
chemical_list: D000925:Anticoagulants; D000074:Acenocoumarol